UVA School of Medicine emeritus professor Dr. Frederick G. Hayden helped design the trial and presented the results Wednesday ...
Scientists have developed a coffee machine-sized 3D bioprinter that produces human-like tissue in a move they hope could potentially speed up the development of new treatments for the likes of heart ...
BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and ...
New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug ...
Pharmaceutical Executive: Can you describe South Rampart’s work in pain medication? Dr. Hernan Bazan: For several years now, we've been working on the development of a novel manipulated small molecule ...
It usually takes more than a decade for a drug company to recoup the amount of money they put into the development of new ...
The American public lacks transparency regarding the origin of their medications, and the assumption that their drugs come ...
Antimalarial drug resistance is a pressing issue in combating the spread of malaria worldwide. In a new study, researchers discovered a key process where malarial parasites take up a human blood cell ...
The investment of over $6 million will expand LGM Pharma’s Rosenberg, Texas manufacturing facility as part of its Phase I ...
2d
News-Medical.Net on MSNNew automated system revolutionizes drug evaluation in zebrafishPreclinical drug evaluation, especially for cardiotoxicity, is a critical stage in the drug development process.
Patients enroll in phase 2 oncology trials seeking access to promising new treatments, but the risk-benefit assessments and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results